{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:44:52Z","timestamp":1784763892955,"version":"3.55.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.blre.2011.01.006","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T15:14:12Z","timestamp":1297782852000},"page":"113-122","source":"Crossref","is-referenced-by-count":10,"title":["Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia"],"prefix":"10.1016","volume":"25","author":[{"given":"Torunn O.","family":"Apelseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Hervig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Bruserud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2011.01.006_bb0005","series-title":"Wintrobe's Clinical Hematology","first-page":"605","article-title":"Megakaryocytes and Platelets","author":"Kaushansky","year":"2004"},{"key":"10.1016\/j.blre.2011.01.006_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1423-0410.2005.00618.x","article-title":"Current methods of assessing platelet function: relevance to transfusion medicine","volume":"88","author":"Cardigan","year":"2005","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2011.01.006_bb0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V66.5.1105.1105","article-title":"Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement","volume":"66","author":"Hanson","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.01.006_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tmrv.2004.03.003","article-title":"Relationship between platelet count and bleeding risk in thrombocytopenic patients","volume":"18","author":"Slichter","year":"2004","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2011.01.006_bb0025","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2011.01.006_bb0030","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1182\/blood-2007-11-123620","article-title":"Inflammation induces hemorrhage in thrombocytopenia","volume":"111","author":"Goerge","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.01.006_bb0035","first-page":"231","article-title":"Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)","volume":"12","author":"Bruserud","year":"2001","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.blre.2011.01.006_bb0040","first-page":"CD004269","article-title":"Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation","author":"Stanworth","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.blre.2011.01.006_bb0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1537-2995.1974.tb04558.x","article-title":"The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study","volume":"14","author":"Higby","year":"1974","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajh.2830120406","article-title":"Indications for platelet transfusion in children with acute leukemia","volume":"12","author":"Murphy","year":"1982","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2011.01.006_bb0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(78)90505-6","article-title":"Platelet prophylaxis in acute non-lymphoblastic leukaemia","volume":"1","author":"Solomon","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2011.01.006_bb0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1705246","article-title":"A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation","volume":"37","author":"Wandt","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2011.01.006_bb0065","series-title":"In ASH","article-title":"Experience with a Therapeutic Platelet Transfusion Strategy in Acute Myeloid Leukemia: Preliminary Results of a Randomized Multicenter Study After Enrolment of 175 Patients","author":"Wandt","year":"2009"},{"key":"10.1016\/j.blre.2011.01.006_bb0070","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.1997.15.3.1143","article-title":"Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10, 000\/microL versus 20, 000\/microL","volume":"15","author":"Heckman","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2011.01.006_bb0075","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.","volume":"337","author":"Rebulla","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2011.01.006_bb0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/bbmt.2002.v8.pm12434952","article-title":"A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10, 000\/L versus 20, 000\/microL trigger","volume":"8","author":"Zumberg","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2011.01.006_bb0085","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1537-2995.2005.04157.x","article-title":"A prospective randomized trial of a prophylactic platelet transfusion trigger of 10\u00d710(9) per L versus 30\u00d710(9) per L in allogeneic hematopoietic progenitor cell transplant recipients","volume":"45","author":"Diedrich","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/asheducation-2008.1.198","article-title":"New strategies for the optimal use of platelet transfusions","volume":"2008","author":"Blajchman","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2011.01.006_bb0095","first-page":"1530","article-title":"The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia","volume":"91","author":"Webert","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2011.01.006_bb0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/asheducation-2007.1.172","article-title":"Evidence-based platelet transfusion guidelines","volume":"2007","author":"Slichter","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2011.01.006_bb0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2141.2005.05769.x","article-title":"Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?","volume":"131","author":"Stanworth","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.01.006_bb0110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1537-2995.2007.01193.x","article-title":"Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10\u00d710(9) and 20\u00d710(9) per L","volume":"47","author":"Nevo","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","article-title":"Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions","volume":"16","author":"Friedmann","year":"2002","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2011.01.006_bb0120","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2011.01.006_bb0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2141.2003.04468.x","article-title":"Guidelines for the use of platelet transfusions","volume":"122","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.01.006_bb0130","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0140-6736(91)92098-M","article-title":"Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia","volume":"338","author":"Gmur","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2011.01.006_bb0135","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM196205032661802","article-title":"The quantitative relation between platelet count and hemorrhage in patients with acute leukemia","volume":"266","author":"Gaydos","year":"1962","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2011.01.006_bb0140","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0308-2261(21)00047-3","article-title":"Thrombocytopenia: mechanisms and management of defects in platelet production","volume":"7","author":"Slichter","year":"1978","journal-title":"Clin Haematol"},{"key":"10.1016\/j.blre.2011.01.006_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1309\/MK3G-MC3V-P06R-PNV2","article-title":"Platelet counting by the coulter LH 750, sysmex XE 2100, and advia 120: a comparative analysis using the RBC\/platelet ratio reference method","volume":"118","author":"Sandhaus","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2011.01.006_bb0150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2141.2004.05352.x","article-title":"Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion","volume":"128","author":"Segal","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.01.006_bb0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cyto.b.20515","article-title":"Comparison of platelet counts by CellDyn Sapphire (Abbot Diagnostics), LH750 (Beckman Coulter), ReaPanThrombo immunoplatelet method (ReaMetrix), and the international flow reference method, in thrombocytopenic blood samples","volume":"78","author":"Sehgal","year":"2010","journal-title":"Cytom B Clin Cytom"},{"key":"10.1016\/j.blre.2011.01.006_bb0160","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2008-09-178236","article-title":"A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia","volume":"113","author":"Heddle","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.01.006_bb0165","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2004-05-1841","article-title":"The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study","volume":"105","author":"Sensebe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.01.006_bb0170","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood.V92.4.1448","article-title":"Platelet transfusion: a dose-response study","volume":"92","author":"Norol","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.01.006_bb0175","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1537-2995.1999.39070674.x","article-title":"Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial","volume":"39","author":"Klumpp","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1537-2995.1973.tb05490.x","article-title":"Prophylactic platelet transfusions in children with acute leukemia: a dose response study","volume":"13","author":"Roy","year":"1973","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0185","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1182\/blood.V93.9.3124","article-title":"A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia","volume":"93","author":"Sagmeister","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.01.006_bb0190","unstructured":"http:\/\/www.controlled-trials.com\/ISRCTN08758735\/platelet+transfusion: A randomised controlled trial of prophylactic versus no-prophylactic platelet transfusions in patients with haematological malignancies. ISRCTN08758735 In. 2006."},{"key":"10.1016\/j.blre.2011.01.006_bb0195","series-title":"Guide to preparation, use and quality assurance of blood components","author":"Council of Europe","year":"2008"},{"key":"10.1016\/j.blre.2011.01.006_bb0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1537-2995.2003.00261.x","article-title":"In vitro evaluation of stored platelets: is there hope for predicting post transfusion platelet survival and function?","volume":"43","author":"Rinder","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0205","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1537-2995.2007.01167.x","article-title":"In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage","volume":"47","author":"Apelseth","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0210","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1537-2995.2006.00800.x","article-title":"Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage","volume":"46","author":"Apelseth","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.0041-1132.2004.00604.x","article-title":"Preliminary validation of a new standard of efficacy for stored platelets","volume":"44","author":"AuBuchon","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1423-0410.2008.01120.x","article-title":"Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: a retrospective analysis of count increment, corrected count increment and transfusion interval","volume":"96","author":"Cid","year":"2009","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2011.01.006_bb0225","first-page":"247","article-title":"A mini-review on platelet refractoriness","volume":"90","author":"Rebulla","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2011.01.006_bb0230","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1537-2995.2009.02540.x","article-title":"Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods","volume":"50","author":"Apelseth","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0235","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1537-2995.2004.03231.x","article-title":"Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers","volume":"44","author":"Cook","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0240","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/bjs.6359","article-title":"The surgical application of point-of-care haemostasis and platelet function testing","volume":"95","author":"Dickinson","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.blre.2011.01.006_bb0245","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1537-2995.1999.39060586.x","article-title":"Corrected count increment and percent platelet recovery as measures of post transfusion platelet response: problems and a solution","volume":"39","author":"Davis","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0250","series-title":"Technical Manual","first-page":"525","article-title":"Platelet and Granulocyte Antigens and Antibodies","year":"2008"},{"key":"10.1016\/j.blre.2011.01.006_bb0255","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","article-title":"A formula to estimate the approximate surface area if height and weight be known","volume":"17","author":"DuBois","year":"1916","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2011.01.006_bb0260","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2011.01.006_bb0265","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2003-12-4443","article-title":"Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial","volume":"104","author":"McCullough","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.01.006_bb0270","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jca.20090","article-title":"Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients","volume":"21","author":"Slichter","year":"2006","journal-title":"J Clin Apher"},{"key":"10.1016\/j.blre.2011.01.006_bb0275","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.0041-1132.2004.04118.x","article-title":"Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design","volume":"44","author":"Tinmouth","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0280","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.hoc.2007.06.010","article-title":"Platelet transfusion therapy","volume":"21","author":"Slichter","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.blre.2011.01.006_bb0285","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/0953710031000118849","article-title":"Influence of platelet count and activity on thromboelastography parameters","volume":"14","author":"Bowbrick","year":"2003","journal-title":"Platelets"},{"issue":"Suppl. 4","key":"10.1016\/j.blre.2011.01.006_bb0290","first-page":"45","article-title":"Thromboelastography and liver transplantation","volume":"21","author":"Gillies","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2011.01.006_bb0295","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1423-0410.2008.01130.x","article-title":"Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study","volume":"96","author":"Johansson","year":"2009","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2011.01.006_bb0300","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1053-0770(05)80189-2","article-title":"Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients","volume":"9","author":"Spiess","year":"1995","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.blre.2011.01.006_bb0305","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MBC.0b013e3282f3f9d4","article-title":"The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass","volume":"19","author":"Reinhofer","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2011.01.006_bb0310","first-page":"311","article-title":"Thrombelastography monitoring of platelet substitution therapy and rFVIIa administration in haemato-oncological patients with severe thrombocytopenia","volume":"105","author":"Salaj","year":"2004","journal-title":"Prague Med Rep"},{"key":"10.1016\/j.blre.2011.01.006_bb0315","unstructured":"T.O. Apelseth, T. Hervig, T. Wentzel-Larsen, K. Petersen, H. Reikvam, O. Bruserud: A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia. Eur Cytokine Netw In press."},{"key":"10.1016\/j.blre.2011.01.006_bb0320","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(07)61198-2","article-title":"Platelet transfusions","volume":"370","author":"Stroncek","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2011.01.006_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1423-0410.1999.7610001.x","article-title":"Prevention and management of platelet transfusion refractoriness","volume":"76","author":"Novotny","year":"1999","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2011.01.006_bb0330","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2011.01.006_bb0335","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1537-2995.1999.39399219278.x","article-title":"A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets","volume":"39","author":"Heddle","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0340","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199409083311001","article-title":"The role of the plasma from platelet concentrates in transfusion reactions","volume":"331","author":"Heddle","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2011.01.006_bb0345","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1537-2995.1999.39111179.x","article-title":"Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations","volume":"39","author":"Kluter","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1537-2995.1993.33393174443.x","article-title":"Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions","volume":"33","author":"Muylle","year":"1993","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0355","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1111\/j.0041-1132.2004.04244.x","article-title":"Risks of transfusion: outcome focus","volume":"44","author":"Spiess","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0360","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1537-2995.2004.03322.x","article-title":"Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes","volume":"44","author":"Spiess","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0365","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1537-2995.2002.00094.x","article-title":"A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets","volume":"42","author":"Heddle","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0370","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.0041-1132.2004.00608.x","article-title":"Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction","volume":"44","author":"Paglino","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0375","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.0041-1132.2003.00518.x","article-title":"The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC","volume":"44","author":"Yazer","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0380","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1537-2995.2003.00458.x","article-title":"Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions","volume":"43","author":"Wakamoto","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0385","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1537-2995.2006.00979.x","article-title":"An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions","volume":"46","author":"Blumberg","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0390","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-3148.2001.00340.x","article-title":"Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice?","volume":"11","author":"Boehlen","year":"2001","journal-title":"Transfus Med"},{"key":"10.1016\/j.blre.2011.01.006_bb0395","series-title":"Immunobiology \u2014 The Immune System in Health and Disease","author":"Janeway","year":"2005"},{"key":"10.1016\/j.blre.2011.01.006_bb0400","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1084\/jem.176.2.587","article-title":"Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils","volume":"176","author":"Kameyoshi","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2011.01.006_bb0405","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4049\/jimmunol.149.2.636","article-title":"RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils","volume":"149","author":"Kuna","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2011.01.006_bb0410","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/ajcp\/106.6.795","article-title":"Cytokine induction of platelet activation","volume":"106","author":"Lumadue","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2011.01.006_bb0415","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/1568009054064651","article-title":"Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies","volume":"5","author":"Hatfield","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.blre.2011.01.006_bb0420","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.leu.2404985","article-title":"Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels","volume":"22","author":"Hatfield","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2011.01.006_bb0425","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/82_2010_25","article-title":"The Chemokine Network in Acute Myelogenous Leukemia: Molecular Mechanisms Involved in Leukemogenesis and Therapeutic Implications","volume":"341","author":"Kittang","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.blre.2011.01.006_bb0430","doi-asserted-by":"crossref","unstructured":"K. Liseth, M. Sjo, K. Paulsen, O. Bruserud, E. Ersvaer: Early pre-engraftment, functional, in vitro responsiveness of T lymphocytes in allotransplanted, acute leukemia patients: proliferation and release of a broad profile of cytokines, possibly predictive of graft-versus-host disease. Eur Cytokine Newt 2010;21:40-49.","DOI":"10.1684\/ecn.2009.0181"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2011.01.006_bb0435","first-page":"S131","article-title":"The chemokine system and its contribution to leukemogenesis and treatment responsiveness in patients with acute myeloid leukemia","volume":"14","author":"Olsnes","year":"2009","journal-title":"J BUON"},{"key":"10.1016\/j.blre.2011.01.006_bb0440","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/09537100701767288","article-title":"Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro","volume":"19","author":"Foss","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2011.01.006_bb0445","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.4161\/cc.5.16.2985","article-title":"Dormant tumors awaken by a short-term angiogenic burst: the spike hypothesis","volume":"5","author":"Indraccolo","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.blre.2011.01.006_bb0450","series-title":"Technical Manual. AABB","first-page":"715","article-title":"Noninfectious Complications of Blood Transfusion","author":"Mazzei","year":"2008"},{"issue":"e5","key":"10.1016\/j.blre.2011.01.006_bb0455","first-page":"22","article-title":"Bacterial contamination of platelet concentrates: pathogen detection and inactivation methods","volume":"1","author":"Vedy","year":"2009","journal-title":"Hematol Rev"},{"key":"10.1016\/j.blre.2011.01.006_bb0460","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1537-2995.1999.39399219279.x","article-title":"Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light","volume":"39","author":"Hei","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0465","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1537-2995.2005.00671.x","article-title":"Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light","volume":"46","author":"Murphy","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0470","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1537-2995.1998.38198141495.x","article-title":"A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion.","volume":"38","author":"Holme","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0475","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1537-2995.2000.4001121.x","article-title":"The absence of swirling in platelet concentrates is highly predictive of poor post transfusion platelet count increments and increased risk of a transfusion reaction","volume":"40","author":"Bertolini","year":"2000","journal-title":"Transfusion"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2011.01.006_bb0480","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1423-0410.1998.tb05422.x","article-title":"Storage and quality assessment of platelets","volume":"74","author":"Holme","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2011.01.006_bb0485","first-page":"144","article-title":"Improved maintenance of platelet in vivo viability during storage when using a synthetic medium with inhibitors","volume":"119","author":"Holme","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.blre.2011.01.006_bb0490","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1423-0410.2002.00172.x","article-title":"Evidence for de novo synthesis of cytokines and chemokines in platelet concentrates","volume":"82","author":"Hartwig","year":"2002","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2011.01.006_bb0495","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1055\/s-0038-1650710","article-title":"Soluble P-selectin as parameter for platelet activation during storage","volume":"76","author":"Kostelijk","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2011.01.006_bb0500","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1538-7836.2010.03837.x","article-title":"CD40 ligand shedding is regulated by interaction of MMP-2 and platelet integrin alphaIIbbeta3","volume":"8","author":"Choi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2011.01.006_bb0505","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1537-2995.2002.00147.x","article-title":"Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study","volume":"42","author":"Dumont","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0510","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1537-2995.1997.37197176945.x","article-title":"The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability","volume":"37","author":"Holme","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0515","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1537-2995.2004.04042.x","article-title":"Role of platelet surface glycoprotein Ibalpha and P-selectin in the clearance of transfused platelet concentrates","volume":"44","author":"Leytin","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0520","doi-asserted-by":"crossref","first-page":"11877","DOI":"10.1073\/pnas.93.21.11877","article-title":"In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function","volume":"93","author":"Michelson","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.blre.2011.01.006_bb0525","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1537-2995.1991.31591263195.x","article-title":"Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion","volume":"31","author":"Rinder","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0530","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood.V92.11.4446","article-title":"P-Selectin and platelet clearance","volume":"92","author":"Berger","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.01.006_bb0535","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/01.CIR.99.19.2577","article-title":"Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb\/IIIa-dependent mechanism","volume":"99","author":"Merten","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2011.01.006_bb0540","first-page":"982","article-title":"Interaction of leukocytes with platelet microparticles derived from outdated platelet concentrates","volume":"80","author":"Miyamoto","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2011.01.006_bb0545","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1537-2995.1992.32592327717.x","article-title":"Storage of platelets in additive solutions: a new method for storage using sodium chloride solution","volume":"32","author":"Gulliksson","year":"1992","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0550","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1537-2995.2005.00202.x","article-title":"Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction","volume":"45","author":"AuBuchon","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0555","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1537-2995.2006.00895.x","article-title":"In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST Collaborative","volume":"46","author":"Dumont","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0560","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1423-0410.2006.00761.x","article-title":"Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects","volume":"90","author":"Goodrich","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2011.01.006_bb0565","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0887-7963(03)00020-8","article-title":"Defining the optimal storage conditions for the long-term storage of platelets","volume":"17","author":"Gulliksson","year":"2003","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2011.01.006_bb0570","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1423-0410.2000.7830176.x","article-title":"Storage of platelets in additive solutions: effects of phosphate","volume":"78","author":"Gulliksson","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2011.01.006_bb0575","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.1995.tb05272.x","article-title":"In vitro platelet ageing at 22 degrees C is reduced compared to in vivo ageing at 37 degrees C","volume":"91","author":"Holme","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.01.006_bb0580","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-0502(03)00048-X","article-title":"Platelet apoptosis in stored platelet concentrates and other models","volume":"28","author":"Leytin","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.blre.2011.01.006_bb0585","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1537-2995.1991.31591263191.x","article-title":"Factors influencing 20-hour increments after platelet transfusion","volume":"31","author":"Bishop","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0590","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1537-2995.2007.01613.x","article-title":"Patient and product factors affecting platelet transfusion results","volume":"48","author":"Heim","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2011.01.006_bb0595","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood-2006-04-020131","article-title":"A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma","volume":"108","author":"Kerkhoffs","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.01.006_bb0600","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting post transfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X11000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X11000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T06:37:09Z","timestamp":1685947029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X11000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0268960X11000075"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2011.01.006","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}